Vasotop 0.625 mg tablets
Vasotop 0.625 mg tablets
Not authorised
- Ramipril
Product identification
Medicine name:
Vasotop 0,625 mg Tabletten
Vasotop 0.625 mg tablets
Active substance:
- Ramipril
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Ramipril0.63/milligram(s)1.00Piece
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QC09AA05
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Ireland
Package description:
- Carton box containing six 15 mL HD polyethylene containers containing 28 tablets closed by LD polypropylene tamper-evident child resistant screw cap. A desiccant capsule is inserted in the cap.
- Carton box containing one 15 mL HD polyethylene container containing 28 tablets closed by LD polypropylene tamper-evident child resistant screw cap. A desiccant capsule is inserted in the cap.
- Carton box containing three 15 mL HD polyethylene containers containing 28 tablets closed by LD polypropylene tamper-evident child resistant screw cap. A desiccant capsule is inserted in the cap.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Intervet (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet GesmbH
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10996/138/004
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0245/001
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
